Varenicline and Alcohol in Inpatient Addictions Program (IAP)

PHASE3TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
AlcoholismNicotine Dependence
Interventions
DRUG

Varenicline

Varenicline is an oral medication with a recommended dosage of 0.5 mg once daily for 3 days, increasing to 0.5 mg twice daily for days 4 to 7, and then to the maintenance dose of 1 mg twice daily for the remaining 23 weeks of treatment. All subjects will receive open-label varenicline in blister packs.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER